China Greenlights Homegrown Covid Shot That Guards Against Dominant Strain

What’s new: China has approved the emergency use of a domestically developed Covid vaccine that guards against what is currently the most dominant strain of the virus globally.

WestVac Biopharma, which co-developed the shot with the West China Hospital of Sichuan University, said in a statement Thursday that the vaccine was the first that targets the omicron XBB subvariant to receive emergency use approval.